Your browser doesn't support javascript.
loading
Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes.
Banks, Samantha A; Bhatti, M Tariq; Go, Ronald S; Abeykoon, Jithma P; Acosta-Medina, Aldo A; Hazim, Antonious Z; Goyal, Gaurav; Young, Jason R; Koster, Matthew J; Vassallo, Robert; Ryu, Jay H; Davidge-Pitts, Caroline J; Ravindran, Aishwarya; Sartori Valinotti, Julio C; Bennani, N Nora; Shah, Mithun V; Rech, Karen L; Garrity, James A; Tobin, W Oliver.
Afiliación
  • Banks SA; Division of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Bhatti MT; Division of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota; Division of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Go RS; Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Abeykoon JP; Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Acosta-Medina AA; Division of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Hazim AZ; Division of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Goyal G; Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Young JR; Division of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Koster MJ; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Vassallo R; Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Ryu JH; Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Davidge-Pitts CJ; Division of Endocrinology, Diabetes, and Nutrition, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Ravindran A; Division of Hematopathology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Sartori Valinotti JC; Division of Dermatology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Bennani NN; Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Shah MV; Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Rech KL; Division of Hematopathology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Garrity JA; Division of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Tobin WO; Division of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota. Electronic address: tobin.oliver@mayo.edu.
Ophthalmology ; 130(1): 77-86, 2023 01.
Article en En | MEDLINE | ID: mdl-35932838
PURPOSE: To evaluate the clinical presentation, treatment, and outcomes in adult patients with histiocytic disorders with ocular, orbital, optic nerve, or cavernous sinus involvement. DESIGN: Observational, retrospective chart review. PARTICIPANTS: Adult patients (age ≥ 18 years) at Mayo Clinic from January 1, 1996, to July 1, 2021, with histiocytic disorders. Inclusion criteria were (1) histiocytic disorder by biopsy and appropriate clinical phenotype; (2) available medical records; and (3) ocular, orbital, optic nerve, or cavernous sinus involvement. METHODS: Retrospective chart review. MAIN OUTCOME MEASURES: Response to therapy, measured in clinical and radiographic impact. RESULTS: Thirty-two patients were identified: 7 with Langerhans cell histiocytosis (LCH); 15 with Erdheim-Chester disease (ECD); 1 with mixed LCH/ECD phenotype; 8 with Rosai-Dorfman disease (RDD); and 1 with mixed RDD/ECD phenotype. Ophthalmologic involvement was part of the initial presentation in 69% of patients (22/32). Eyelid edema (13/32, 41%) and proptosis (12/32, 38%) were the most frequent presentations. Isolated orbital or cavernous sinus involvement was present in 3 of 7 patients with LCH and 1 of 8 patients with RDD. Optic nerve sheath involvement was present in 2 of 7 LCH patients, 14 of 15 ECD patients, and 1 RDD/ECD patient. Diffuse (> 75%) orbital involvement was seen in 12 of 15 ECD patients and 1 of 7 LCH patients. Ocular involvement was seen in 1 of 15 ECD patients, 6 of 8 RDD patients, and 1 of 1 mixed RDD/ECD patient. The cavernous sinuses were involved in 1 of 7 LCH patients, 5 of 15 ECD patients, and both mixed phenotype patients. Visual acuity was affected in 14 patients (14/24, 58%) with a median logarithm of the minimum angle of resolution visual acuity of 0.1 (range, -0.12 to 3). BRAF V600E mutations were found in 75% (3/4) of LCH patients and 91% (10/11) of ECD patients. Patients received a variety of treatment, and response was variable across disease types. CONCLUSIONS: Orbital involvement was more commonly seen in LCH and ECD, whereas ocular involvement was more common in RDD. Visual acuity may be impacted from ocular involvement or compression of the optic nerve with diffuse orbital involvement.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Exoftalmia / Histiocitosis de Células de Langerhans / Enfermedad de Erdheim-Chester Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ophthalmology Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Exoftalmia / Histiocitosis de Células de Langerhans / Enfermedad de Erdheim-Chester Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ophthalmology Año: 2023 Tipo del documento: Article